Tissue Plasminogen Activator (tPA) and Matrix Metalloproteinases in the Pathogenesis of Stroke: Therapeutic Strategies

E-ISSN： 1996-3181|7|3|243-253

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.7, Iss.3, 2008-06, pp. : 243-253

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Tissue-type plasminogen activator as a therapeutic target in stroke

By Gravanis Iordanis Tsirka Stella E

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 2, 2008-02 ,pp. : 159-170

Informa Healthcare

Access to resources Recommend Favorite

Targeting Extracellular Matrix Proteolysis for Hemorrhagic Complications of tPA Stroke Therapy

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 7, Iss. 3, 2008-06 ,pp. : 235-242

Bentham Science Publishers

Access to resources Recommend Favorite

Complications Associated with Recombinant Tissue Plasminogen Activator Therapy for Acute Ischaemic Stroke

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 2, 2013-04 ,pp. : 155-169

Bentham Science Publishers

Access to resources Recommend Favorite

Vascular Protection to Increase the Safety of Tissue Plasminogen Activator for Stroke

Current Pharmaceutical Design, Vol. 18, Iss. 25, 2012-07 ,pp. : 3677-3684

Bentham Science Publishers

Access to resources Recommend Favorite

Intravenous Thrombolysis with Recombinant Tissue Plasminogen Activator (rt-PA) in Acute Lower Limb Ischaemia

By Flis V Kobilica N Bergauer A Mrdža B Milotič F Štirn B

The Journal of International Medical Research, Vol. 39, Iss. 3, 2011-05 ,pp. : 1107-1112

Field House Publishing

Access to resources Recommend Favorite